Andere Sprachen Brain+ A/S

Aktien

A3C5G6

DK0061670205

BRAINP

Markt geschlossen - Nasdaq Copenhagen Andere Börsenplätze 16:50:18 03.05.2024			% 5 Tage	% 1. Jan.
0.1285 ^DKK	+7.53%		-0.77%	-33.76%

09.02.	Brain+ arbeitet mit Quiddity Health zusammen, um Software für kognitive Stimulationstherapie in Großbritannien einzuführen	MT
09.02.	Brain+ A/S geht Partnerschaft mit Quiddity Health ein, um den Markteintritt von CST-Therapist Companion in Großbritannien vorzubereiten	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark	02.05.
Brain+' CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia	30.04.
Brain+ releases preliminary annual financial statements for 2023	30.04.
Brain+ announces a change in its Financial Calendar for 2024	29.04.
Successful educational CST course held with Malteser Germany based on the CST-Assistant	26.04.
Certain Shares of Brain+ A/S are subject to a Lock-Up Agreement Ending on 22-APR-2024.	22.04.
Brain+ announces registration of directed issue with the Danish Business Authority	11.04.
Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority	10.04.
Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments	26.03.
Brain+ A/S specifies how to get TO 3 warrant compensation	26.03.
Brain+ A/S announces last day of trading in its warrants of series TO 3	20.03.
Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK	19.03.
Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025	18.03.
Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments	15.03.
Brain+ announces that 58% of its warrants of series TO 3 are covered by early commitments	11.03.
Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise	07.03.
Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate	12.02.
Brain+ Teams Up with Quiddity Health to Launch Cognitive Stimulation Therapy Software in UK	09.02.
Brain+ partners with Quiddity Health, the #1 UK digital healthcare market specialist, to prepare UK market entry for CST-Therapist Companion	09.02.
Brain+ A/S Partners with Quiddity Health to Prepare UK Market Entry for CST-Therapist Companion	09.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Brain+ A/S

Aktien

A3C5G6

DK0061670205

BRAINP

Andere Sprachen

Filter